{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T10:57:19Z","timestamp":1769857039640,"version":"3.49.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T00:00:00Z","timestamp":1680048000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.diagmicrobio.2023.115946","type":"journal-article","created":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T21:10:50Z","timestamp":1680124250000},"page":"115946","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Analysis of the effect of urine on the in vitro activity of gepotidacin and levofloxacin against Escherichia coli, Staphylococcus epidermidis, and Staphylococcus saprophyticus"],"prefix":"10.1016","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2885-6129","authenticated-orcid":false,"given":"Laura M.","family":"Koeth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeanna M.","family":"DiFranco-Fisher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole E.","family":"Scangarella-Oman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.diagmicrobio.2023.115946_bib0001","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00199-20","article-title":"Phase 2a pharmacokinetic, safety, and exploratory efficacy evaluation of oral gepotidacin (GSK2140944) in female participants with uncomplicated urinary tract infection (Acute Uncomplicated Cystitis)","volume":"64","author":"Overcash","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2023.115946_bib0002","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01492-21","article-title":"Dose selection for phase III clinical evaluation of gepotidacin (GSK2140944) in the treatment of uncomplicated urinary tract infections","volume":"66","author":"Scangarella-Oman","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2023.115946_bib0003","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00468-17","article-title":"Gepotidacin (GSK 2140944) in vitro activity against gram-positive and gram-negative bacteria","volume":"61","author":"Flamm","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2023.115946_bib0004","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1128\/AAC.02820-15","article-title":"In vitro activity of gepotidacin, a novel triazaacenaphthylene bacterial topoisomerase inhibitor, against a broad spectrum of bacterial pathogens","volume":"60","author":"Biedenbach","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2023.115946_bib0005","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1021\/acsinfecdis.8b00315","article-title":"Mechanistic and structural basis for the actions of the antibacterial gepotidacin against staphylococcus aureus gyrase","volume":"5","author":"Gibson","year":"2019","journal-title":"ACS Infect Dis"},{"issue":"7309","key":"10.1016\/j.diagmicrobio.2023.115946_bib0006","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/nature09197","article-title":"Type IIA topoisomerase inhibition by a new class of antibacterial agents","volume":"466","author":"Bax","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.diagmicrobio.2023.115946_bib0007","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically","year":"2018"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2023.115946_bib0008","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02498-16","article-title":"Pharmacodynamic evaluation of fosfomycin against Escherichia coli and Klebsiella spp. from urinary tract infections and the influence of pH on fosfomycin activities","volume":"61","author":"Fedrigo","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2023.115946_bib0009","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.urology.2014.04.048","article-title":"The influence of urinary pH on antibiotic efficacy against bacterial uropathogens","volume":"84","author":"Yang","year":"2014","journal-title":"Urology"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2023.115946_bib0010","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1128\/JCM.02411-06","article-title":"Factors influencing broth microdilution antimicrobial susceptibility test results for dalbavancin, a new glycopeptide agent","volume":"45","author":"Rennie","year":"2017","journal-title":"J Clin Microbiol"},{"issue":"9","key":"10.1016\/j.diagmicrobio.2023.115946_bib0011","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1128\/JCM.40.9.3269-3276.2002","article-title":"Effects of various test media on the activities of 21 antimicrobial agents against Haemophilus influenzae","volume":"40","author":"Jacobs","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2023.115946_bib0012","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/jac\/46.3.369","article-title":"Comparison of cation-adjusted Mueller-Hinton broth with Iso-Sensitest broth for the NCCLS broth microdilution method","volume":"46","author":"Koeth","year":"2000","journal-title":"J Antimicrobial Chemotherap"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2023.115946_bib0013","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1128\/jcm.35.4.1027-1029.1997","article-title":"Effect of zinc concentration in Mueller-Hinton agar on susceptibility of Pseudomonas aeruginosa to imipenem","volume":"35","author":"Daly","year":"1997","journal-title":"J Clin Microbiol"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2023.115946_bib0014","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1128\/jcm.35.6.1311-1315.1997","article-title":"Variability in susceptibilities of Haemophilus influenzae to clarithromycin and azithromycin due to medium pH","volume":"35","author":"Nilius","year":"1997","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2023.115946_bib0015","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0732-8893(96)00179-4","article-title":"Medium and supplement effects on the antimicrobial activity of quinupristin\/dalfopristin tested by agar dilution and Etest methods","volume":"26","author":"Jones","year":"1996","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2023.115946_bib0016","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/BF01970957","article-title":"Effect of pathological changes of pH, pO2 and pCO2 on the activity of antimicrobial agents in vitro","volume":"12","author":"Konig","year":"1993","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2023.115946_bib0017","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0732-8893(88)90058-2","article-title":"Group G Streptococci: susceptibility patterns and the effect of the inoculum size and growth phase on the bactericidal activity of penicillin","volume":"9","author":"Libertin","year":"1988","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2023.115946_bib0018","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1128\/jcm.23.5.959-961.1986","article-title":"Effect of storage temperature and pH on the stability of antimicrobial agents in MIC trays","volume":"23","author":"Hwang","year":"1986","journal-title":"J Clin Microbiol"},{"issue":"Suppl B","key":"10.1016\/j.diagmicrobio.2023.115946_bib0019","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/jac\/17.suppl_B.29","article-title":"In-vitro activity of newer quinolones against aerobic bacteria","volume":"17","author":"Auckenthaler","year":"1986","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2023.115946_bib0020","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/infdis\/137.2.103","article-title":"Effect of cation content of agar on the activity of gentamicin, tobramycin, and amikacin against Pseudomonas aeruginosa","volume":"137","author":"Washington","year":"1978","journal-title":"J Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2023.115946_bib0021","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ebiom.2017.08.021","article-title":"Reversion of high-level mecillinam resistance to susceptibility in Escherichia coli during growth in urine","volume":"23","author":"Thulin","year":"2017","journal-title":"EBioMedicine"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2023.115946_bib0022","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1128\/AAC.00602-16","article-title":"Urinary Tract Physiological conditions promote ciprofloxacin resistance in low-level-quinolone-resistant Escherichia coli","volume":"60","author":"Mart\u00edn-Guti\u00e9rrez","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"5-6","key":"10.1016\/j.diagmicrobio.2023.115946_bib0023","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000342423","article-title":"Impact of pH on activity of trimethoprim, fosfomycin, amikacin, colistin and ertapenem in human urine","volume":"90","author":"Burian","year":"2012","journal-title":"Pharmacology"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2023.115946_bib0024","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.resmic.2011.01.004","article-title":"Impact of pH on bacterial growth and activity of recent fluoroquinolones in pooled urine","volume":"162","author":"Erdogan-Yildirim","year":"2011","journal-title":"Res Microbiol"},{"key":"10.1016\/j.diagmicrobio.2023.115946_bib0025","unstructured":"CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 32nd Informational Supplement 2022; M100-S32. CLSI, Wayne, PA."},{"issue":"6","key":"10.1016\/j.diagmicrobio.2023.115946_bib0026","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1128\/JCM.02366-16","article-title":"Analysis of MIC and disk diffusion testing variables for gepotidacin and comparator agents against select bacterial pathogens","volume":"55","author":"Koeth","year":"2017","journal-title":"J Clin Microbio"},{"issue":"9","key":"10.1016\/j.diagmicrobio.2023.115946_bib0027","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1093\/jac\/dky232","article-title":"Variation of MIC measurements: the contribution of strain and laboratory variability to measurement precision","volume":"73","author":"Mouton","year":"2018","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2023.115946_bib0028","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02245-17","article-title":"Cellular pharmacokinetics and intracellular activity of gepotidacin against staphylococcus aureus isolates with different resistance phenotypes in models of cultured phagocytic cells","volume":"62","author":"Peyrusson","year":"2018","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889323000561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889323000561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:58:49Z","timestamp":1760003929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889323000561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S0732889323000561"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2023.115946","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of the effect of urine on the in vitro activity of gepotidacin and levofloxacin against Escherichia coli, Staphylococcus epidermidis, and Staphylococcus saprophyticus","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2023.115946","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115946"}}